United States · FDA National Drug Code directory
Tobramycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-305_c55fcee9-70c7-4926-bee6-014c0b133249
- Product NDC
- 63323-305
- Form
- INJECTION, SOLUTION
- Composition / generic term
- TOBRAMYCIN SULFATE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041130
- Source listing expiry
- 20261231
Source-listed ingredients
- TOBRAMYCIN SULFATE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, MULTI-DOSE in 1 TRAY (63323-305-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-305-01) · 63323-305-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →